Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage. 


BACKGROUND: Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known.

METHODS: In this multicenter, randomized trial involving patients with an acute intracerebral hemorrhage, we assessed surgical removal of the hematoma as compared with medical management. Patients who had a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 ml were assigned, in a 1:1 ratio, within 24 hours after the time that they were last known to be well, to minimally invasive surgical removal of the hematoma plus guideline-based medical management (surgery group) or to guideline-based medical management alone (control group). The primary efficacy end point was the mean score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes, according to patients’ assessment) at 180 days, with a prespecified threshold for posterior probability of superiority of 0.975 or higher. The trial included rules for adaptation of enrollment criteria on the basis of hemorrhage location. A primary safety end point was death within 30 days after enrollment.

RESULTS: A total of 300 patients were enrolled, of whom 30.7% had anterior basal ganglia hemorrhages and 69.3% had lobar hemorrhages. After 175 patients had been enrolled, an adaptation rule was triggered, and only persons with lobar hemorrhages were enrolled. The mean score on the utility-weighted modified Rankin scale at 180 days was 0.458 in the surgery group and 0.374 in the control group (difference, 0.084; 95% Bayesian credible interval, 0.005 to 0.163; posterior probability of superiority of surgery, 0.981). The mean between-group difference was 0.127 (95% Bayesian credible interval, 0.035 to 0.219) among patients with lobar hemorrhages and -0.013 (95% Bayesian credible interval, -0.147 to 0.116) among those with anterior basal ganglia hemorrhages. The percentage of patients who had died by 30 days was 9.3% in the surgery group and 18.0% in the control group. Five patients (3.3%) in the surgery group had postoperative rebleeding and neurologic deterioration.

CONCLUSIONS: Among patients in whom surgery could be performed within 24 hours after an acute intracerebral hemorrhage, minimally invasive hematoma evacuation resulted in better functional outcomes at 180 days than those with guideline-based medical management. The effect of surgery appeared to be attributable to intervention for lobar hemorrhages.

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage


Abstract

BACKGROUND

Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known.

METHODS

In this multicenter, randomized trial involving patients with an acute intracerebral hemorrhage, we assessed surgical removal of the hematoma as compared with medical management. Patients who had a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 ml were assigned, in a 1:1 ratio, within 24 hours after the time that they were last known to be well, to minimally invasive surgical removal of the hematoma plus guideline-based medical management (surgery group) or to guideline-based medical management alone (control group). The primary efficacy end point was the mean score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes, according to patients’ assessment) at 180 days, with a prespecified threshold for posterior probability of superiority of 0.975 or higher. The trial included rules for adaptation of enrollment criteria on the basis of hemorrhage location. A primary safety end point was death within 30 days after enrollment.

Download a PDF of the Research Summary.

RESULTS

A total of 300 patients were enrolled, of whom 30.7% had anterior basal ganglia hemorrhages and 69.3% had lobar hemorrhages. After 175 patients had been enrolled, an adaptation rule was triggered, and only persons with lobar hemorrhages were enrolled. The mean score on the utility-weighted modified Rankin scale at 180 days was 0.458 in the surgery group and 0.374 in the control group (difference, 0.084; 95% Bayesian credible interval, 0.005 to 0.163; posterior probability of superiority of surgery, 0.981). The mean between-group difference was 0.127 (95% Bayesian credible interval, 0.035 to 0.219) among patients with lobar hemorrhages and −0.013 (95% Bayesian credible interval, −0.147 to 0.116) among those with anterior basal ganglia hemorrhages. The percentage of patients who had died by 30 days was 9.3% in the surgery group and 18.0% in the control group. Five patients (3.3%) in the surgery group had postoperative rebleeding and neurologic deterioration.

CONCLUSIONS

Among patients in whom surgery could be performed within 24 hours after an acute intracerebral hemorrhage, minimally invasive hematoma evacuation resulted in better functional outcomes at 180 days than those with guideline-based medical management. The effect of surgery appeared to be attributable to intervention for lobar hemorrhages.

Trial of Early Minimally Invasive Removal of Intracerebral Hemorrhage


Abstract

BACKGROUND

Trials of surgical evacuation of supratentorial intracerebral hemorrhages have generally shown no functional benefit. Whether early minimally invasive surgical removal would result in better outcomes than medical management is not known.

METHODS

In this multicenter, randomized trial involving patients with an acute intracerebral hemorrhage, we assessed surgical removal of the hematoma as compared with medical management. Patients who had a lobar or anterior basal ganglia hemorrhage with a hematoma volume of 30 to 80 ml were assigned, in a 1:1 ratio, within 24 hours after the time that they were last known to be well, to minimally invasive surgical removal of the hematoma plus guideline-based medical management (surgery group) or to guideline-based medical management alone (control group). The primary efficacy end point was the mean score on the utility-weighted modified Rankin scale (range, 0 to 1, with higher scores indicating better outcomes, according to patients’ assessment) at 180 days, with a prespecified threshold for posterior probability of superiority of 0.975 or higher. The trial included rules for adaptation of enrollment criteria on the basis of hemorrhage location. A primary safety end point was death within 30 days after enrollment.

Download a PDF of the Research Summary.

RESULTS

A total of 300 patients were enrolled, of whom 30.7% had anterior basal ganglia hemorrhages and 69.3% had lobar hemorrhages. After 175 patients had been enrolled, an adaptation rule was triggered, and only persons with lobar hemorrhages were enrolled. The mean score on the utility-weighted modified Rankin scale at 180 days was 0.458 in the surgery group and 0.374 in the control group (difference, 0.084; 95% Bayesian credible interval, 0.005 to 0.163; posterior probability of superiority of surgery, 0.981). The mean between-group difference was 0.127 (95% Bayesian credible interval, 0.035 to 0.219) among patients with lobar hemorrhages and −0.013 (95% Bayesian credible interval, −0.147 to 0.116) among those with anterior basal ganglia hemorrhages. The percentage of patients who had died by 30 days was 9.3% in the surgery group and 18.0% in the control group. Five patients (3.3%) in the surgery group had postoperative rebleeding and neurologic deterioration.

CONCLUSIONS

Among patients in whom surgery could be performed within 24 hours after an acute intracerebral hemorrhage, minimally invasive hematoma evacuation resulted in better functional outcomes at 180 days than those with guideline-based medical management. The effect of surgery appeared to be attributable to intervention for lobar hemorrhages.

The ABCs of Measuring Intracerebral Hemorrhage Volumes


Abstract

Background and Purpose Hemorrhage volume is a powerful predictor of 30-day mortality after spontaneous intracerebral hemorrhage (ICH). We compared a bedside method of measuring CT ICH volume with measurements made by computer-assisted planimetric image analysis.

Methods The formula ABC/2 was used, where A is the greatest hemorrhage diameter by CT, B is the diameter 90° to A, and C is the approximate number of CT slices with hemorrhage multiplied by the slice thickness.

Results The ICH volumes for 118 patients were evaluated in a mean of 38 seconds and correlated with planimetric measurements (R2=.96). Interrater and intrarater reliability were excellent, with an intraclass correlation of .99 for both.

Conclusions We conclude that ICH volume can be accurately estimated in less than 1 minute with the simple formula ABC/2.

 

  • Introduction

The 30-day mortality rate of intracerebral hemorrhage (ICH) is approximately 44%, with almost half of the patients dying within the first 48 hours.1 There is no proven effective treatment, and the ability to rapidly determine a patient’s prognosis at the bedside would be a powerful tool in selecting and stratifying patients in future trials of surgical intervention. Hemorrhage volume, level of consciousness, and the presence of intraventricular extension have all been documented as predictors of ICH outcome.2 The latter two can be easily evaluated. We compare a bedside method of ICH volume measurement3 with a computerized planimetric measurement.

Subjects and Methods

One hundred eighteen patients with spontaneous ICH were assessed prospectively with CT within 3 hours of symptom onset. Exclusion criteria included (1) CT evidence of a subarachnoid hemorrhage, (2) history of recent trauma, (3) isolated intraventricular hemorrhage, and (4) ICH due to aneurysm or arteriovenous malformation. Hemorrhage volumes were measured by a computerized planimetric method and a simplified formula for the volume of an ellipsoid, ABC/2 (see “Appendix”). Measurement by planimetrics is an established and accurate method of measuring ICH volume that uses computer-assisted image analysis.2 4 5

For the bedside ABC/2 method, the CT slice with the largest area of hemorrhage was identified. The largest diameter (A) of the hemorrhage on this slice was measured. The largest diameter 90° to A on the same slice was measured next (B). Finally, the approximate number of 10-mm slices on which the ICH was seen was calculated (C). C was calculated by a comparison of each CT slice with hemorrhage to the CT slice with the largest hemorrhage on that scan. If the hemorrhage area for a particular slice was greater than 75% of the area seen on the slice where the hemorrhage was largest, the slice was considered 1 hemorrhage slice for determining C. If the area was approximately 25% to 75% of the area, the slice was considered half a hemorrhage slice; and if the area was less than 25% of the largest hemorrhage, the slice was not considered a hemorrhage slice. These CT hemorrhage slice values were then added to determine the value for C. All measurements for A and B were made with the use of the centimeter scale on the CT scan to the nearest 0.5 cm. A, B, and C were then multiplied and the product divided by 2, which yielded the volume of hemorrhage in cubic centimeters. The time required for the measurements and calculations was recorded. Hemorrhage volumes determined by the two techniques were then compared by regression analysis.

Twenty CT scans were randomly selected from the study population of 118, and hemorrhage volumes were measured by four individuals (a neurosurgery faculty member [M.Z.], a third-year neurosurgery resident, an emergency medicine faculty member [R.U.K], and a registered nurse [L.R.S.]) with the ABC/2 technique.

We evaluated intrarater reliability for a single reader by comparing initial measurements of these 20 CT scans using the ABC/2 method with repeated measurements by the same investigator using the same technique.

Results

Of the 118 patients evaluated, 83 (70%) were deep hemorrhages, 21 (18%) were lobar, 8 (7%) were brain stem, and 6 (5%) were cerebellar. The correlation between measurements by planimetric and ABC/2 methods was very high (R2=.96). Measurements by a single reader using the ABC/2 method correlated well with planimetric measurements for all hemorrhage locations (Table 1). The ABC/2 method overestimated hemorrhage volume by 1.5±1.3 cm3. The ABC/2 method required a mean time of 38 seconds (range, 70 to 210 seconds). In the subset of 20 CT scans measured by four different readers, we noted excellent interrater (intraclass correlation=.99) and intrarater (intraclass correlation=.99) reliability when the ABC/2 technique was used (Table 2). The mean time per measurement for the readers ranged from 31 to 40 seconds.

Reliability and Reproducibility of the ABC/2 Method of Measuring Intraparenchymal Hemorrhage Volume

Discussion

A number of techniques have been developed to measure hemorrhage volume.2 6 7 8 Unfortunately, these methods often involve complicated formulas, require specialized equipment, or cannot be performed rapidly at the patient’s bedside. We found that the simple formula ABC/2 can accurately estimate intraparenchymal hemorrhage volume and requires less than 1 minute for measurement and calculation. The measurements correlate highly with the volumes calculated by planimetric methods for all hemorrhage locations.

Rapid calculation of ICH volume at the time of initial patient presentation has clinical utility. For prognosis, a model of 30-day mortality that used the Glasgow Coma Scale and hemorrhage volume in patients with ICH correctly predicted outcome with a sensitivity and specificity of 97%.2 The ABC/2 technique may also be used to identify appropriate patients with ICH suitable for randomization into therapeutic trials.3 For example, the technique is the measurement method used for patient eligibility assessment in the multicenter Surgical Trial of Intracerebral Hemorrhage (J. Grotta, unpublished data, 1996). In this trial, patients with ICH and anticipated good outcome are not eligible for surgery. Thus, patients with hemorrhage volumes of less than 10 cm3 and patients with lobar hemorrhage volumes of 10 to 20 cm3 with minimal or no neurological deficits are excluded.

The ABC/2 and other bedside techniques of calculating hemorrhage volumes have been described previously.3 5 6 Lisk and colleagues3 demonstrated the ease and power of theABC/2 method of volume measurement in a model of outcome after ICH but did not correlate this technique with other methods of volume measurement. The ABC/2 formula can be adjusted for CT slices of varying thickness by multiplying the number of slices of the different thicknesses on which the hematoma is seen (C of ABC/2) by the slice thickness in centimeters. Other authors have estimated hematoma volume by assuming it to approximate the volume of a sphere, an ellipsoid, or a rectangulopiped.2 7 8 Only estimates of volume that use the formula for an ellipsoid have been shown to correlate with planimetric techniques.5

In conclusion, intraparenchymal hemorrhage volume can be accurately estimated in less than 1 minute with the simple formula ABC/2. This rapid method of measuring hemorrhage volume may allow physicians to quickly select and stratify patients in future treatment trials.

Appendix

The derivation of the ABC/2 formula is as follows: The volume of an ellipsoid is 4/3π(A/2)(B/2)(C/2), where A, B, and C are the three diameters. If π is estimated to be 3, then the volume of an ellipsoid becomes ABC/2.

Footnotes

  • Reprint requests to Rashmi Kothari, MD, Department of Emergency Medicine, University of Cincinnati College of Medicine, PO Box 670769, Cincinnati, OH 45267-0769. E-mailRashmikant.Kothari@uc.edu.

  • Received December 28, 1995.
  • Revision received April 17, 1996.
  • Accepted April 17, 1996.

References

Low Vitamin C Linked to Intracerebral Hemorrhage.


A new study finds a link between vitamin C depletion and increased risk for intracerebral hemorrhage (ICH).

In a case–control study, researchers found vitamin C depletion was more common among ICH cases than matched controls.

“This original study suggests that a low plasma vitamin C concentration is a risk for spontaneous intracerebral hemorrhages,” lead researcher Stephane Vannier, MD, a neurologist at Pontchaillou University Hospital, Rennes, France, told Medscape Medical News.

“This link is probably associated with the role of vitamin C in blood pressure regulation and collagen biosynthesis,” although other factors may also play a role, said Dr. Vannier.

These findings, he added, provide the rationale for clinical trials to test the efficacy of vitamin C supplementation in preventing hemorrhagic stroke and minimizing infectious or cutaneous complications in those sustaining an ICH.

The study will be released at the upcoming 66th Annual Meeting of the American Academy of Neurology annual meeting in Philadelphia, Pennsylvania.

Risk Factors for ICH

The prospective case–control study included 135 participants, whose mean plasma vitamin C concentration was 45.8 µmol/L. Of these participants, 41% had a normal vitamin C status (more than 38 µmol/L), 45% showed some depletion (11 to 38 µmol/L), and 14% were deficient (less than 11 µmol/L).

The vitamin C concentration was significantly lower in the 65 participants who had experienced a spontaneous ICH than in the 65 healthy controls, said Dr. Vannier. However, he and his research colleagues have not yet calculated an odds risk.

The study found that strong risk factors for deep ICH were hypertension ( P = .008), alcohol consumption ( P = .023), and being overweight ( P = .038). The researchers also noted that patients with a lobar ICH were significantly older than those with a deep ICH.

As well as increasing the risk for infection by altering the immune response, vitamin C deficiency has many other health implications. Vitamin C (ascorbic acid) is an effective antioxidant and might counter the oxidative stress that plays a role in the etiology of high blood pressure. Dr. Vannier noted that most hypertensive patients in the study were vitamin C depleted.

Not getting enough vitamin C may increase risks for atherosclerosis and heart disease, as well as hypertension.

“Vitamin C decreases blood pressure, which may partly explain the association between fruit and vegetable intake and mortality from stroke,” said Dr. Vanier. “Moreover, ascorbic acid contributes to collagen biosynthesis and regulation, including that of basal membrane vessel type IV collagen. Depletion is responsible for unstable and dysfunctional collagen with loss of organ support properties, which may lead to hemorrhages.”

Boosting Vitamin C Intake

The study authors made several other important observations. For example, length of stay in the neurology care unit was significantly shorter (9.8 days) for patients with normal vitamin C status than for those with vitamin C depletion (18.2 days).

The longer hospital stay may be the result of complication-related infections in patients with a vitamin C deficiency, said Dr. Vannier. Or, those with vitamin C depletion may be dealing with skin disorders, such as ulcerations, pressure ulcers, and delayed healing of existing lesions.

“Larger studies are needed to explore these relationships and hypotheses, but it seems that we should be treating vitamin C deficiency with ascorbic acid supplementation and increased fruit and vegetable intake to limit infectious and cutaneous complications,” said Dr. Vannier.

Environmental factors are probably also involved in the relationship between vitamin C deficiency and ICH, but more studies are needed in this area, too, said Dr. Vannier.

Experts recommend 120 mg of vitamin C daily, according to Dr. Vannier. Although a balanced diet with plenty of fresh fruit and vegetables should provide adequate levels, patients might try boosting their intake of foods rich in the vitamin, such as raw peppers (any kind), which contain about 200 mg/100 g; fresh orange juice, which has about 60 mg per 100 g; black currants; or parsley.

At this point, experts don’t recommend vitamin C supplementation if there is no deficiency, said Dr. Vannier.

The vitamin C–ICH connection is not far-fetched, the researchers note. Hemorrhagic syndrome and occasionally ICH were among the clinical manifestations of scurvy, a devastating disease of vitamin C deficiency that plagued sailors of bygone years who didn’t have access to fresh fruit and vegetables.

A randomized controlled study comparing omeprazole and cimetidine for the prophylaxis of stress-related upper gastrointestinal bleeding in patients with intracerebral hemorrhage.


Patients with intracerebral hemorrhage (ICH) are at high risk for severe stress-related upper gastrointestinal (UGI) bleeding, which is predictive of higher mortality. The aim of this study was to evaluate the effectiveness of omeprazole and cimetidine compared with a placebo in the prevention and management of stress-related UGI bleeding in patients with ICH.

Methods

In a single-center, randomized, placebo-controlled study, 184 surgically treated patients with CT-proven ICH within 72 hours of ictus and negative results for gastric occult blood testing were included. Of these patients, 165 who were qualified upon further evaluation were randomized into 3 groups: 58 patients received 40 mg intravenous omeprazole every 12 hours, 54 patients received 300 mg intravenous cimetidine every 6 hours, and 53 patients received a placebo. Patients whose gastric occult blood tests were positive at admission (n = 70) and during/after the prophylaxis procedure (n = 48) were treated with high-dose omeprazole at 80 mg bolus plus 8 mg/hr infusion for 3 days, followed by 40 mg intravenous omeprazole every 12 hours for 7 days.

Results

Of the 165 assessable patients, stress-related UGI bleeding occurred in 9 (15.5%) in the omeprazole group compared with 15 patients (27.8%) in the cimetidine group and 24 patients (45.3%) in the placebo group (p = 0.003). The occurrence of UGI bleeding was significantly related to death (p = 0.022). Nosocomial pneumonia occurred in 14 patients (24.1%) receiving omeprazole, 12 (22.2%) receiving cimetidine, and 8 (15.1%) receiving placebo (p > 0.05). In patients with UGI bleeding in which high-dose omeprazole was initiated, UGI bleeding arrested within the first 3 days in 103 patients (87.3%).

Conclusions

Omeprazole significantly reduced the morbidity of stress-related UGI bleeding in patients with ICH due to its effective prophylactic effect without increasing the risk of nosocomial pneumonia, but it did not reduce the 1-month mortality or ICU stay. Further evaluation of high-dose omeprazole as the drug of choice for patients presenting with UGI bleeding is warranted.

Source: Journal of Neurosurgery

 

 

 

 

Computed tomography angiography: improving diagnostic yield and cost effectiveness in the initial evaluation of spontaneous nonsubarachnoid intracerebral hemorrhage.


Computed tomography angiography (CTA) is increasingly used as a screening tool in the investigation of spontaneous intracerebral hemorrhage (ICH). However, CTA carries additional costs and risks, necessitating its judicious use. The authors hypothesized that subsets of patients with nontraumatic, nonsubarachnoid ICH are unlikely to benefit from CTA as part of the diagnostic workup and that particular patient risk factors may be used to increase the yield of CTA in the detection of vascular sources.

Methods

The authors performed a retrospective analysis of 1376 patients admitted to Dartmouth-Hitchcock Medical Center with ICH over an 8-year period. Patients with subarachnoid hemorrhage, hemorrhagic conversion of ischemic infarcts, trauma, and known prior malignancy were excluded from the analysis, resulting in 257 patients for final analysis. Records were reviewed for medical risk factors, hemorrhage location, and correlation of CTA findings with final diagnosis. Multiple logistic regression analysis was used to investigate the combined effects of baseline variables of interest. Model selection was conducted using the stepwise method with p = 0.10 as the significance level for variable entry and p = 0.05 the significance level for variable retention.

Results

Computed tomography angiography studies detected vascular pathology in 34 patients (13.2%). Patient characteristics that were associated with a significantly higher likelihood of identifying a structural vascular lesion as the source of hemorrhage included patient age younger than 65 years (OR = 16.36, p = 0.0039), female sex (OR = 14.9, p = 0.0126), nonsmokers (OR = 103.8, p = 0.0008), patients with intraventricular hemorrhage (OR = 9.42, p = 0.0379), and patients without hypertension (OR = 515.78, p < 0.0001). Patients who were older than 65 years of age, with a history of hypertension, and hemorrhage located in the cerebellum or basal ganglia were never found to have an identified structural source of hemorrhage on CTA.

Conclusions

Patient characteristics and risk factors are important considerations when ordering diagnostic tests in the workup of nonsubarachnoid, nontraumatic spontaneous ICH. Although CTA is an accurate diagnostic examination, it can usually be omitted in the workup of patients with the described characteristics. The use of this algorithm has the potential to increase the yield, and thus the safety and cost effectiveness, of this diagnostic tool.

Source: Journal of Neurosurgery.